DVAX250516C10000
- 1.20
- 0.000.00%
Dynavax Technologies Newsroom
Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits
Trump Administration Said to Be Investing $500M on Developing Universal Vaccines
Earnings Preview: DVAX to Report Financial Results Post-market on May 06
Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
Why Investors Shouldn't Be Surprised By Dynavax Technologies Corporation's (NASDAQ:DVAX) 25% Share Price Plunge
Dynavax Technologies Analyst Ratings
Express News | Dynavax Technologies Corp - Urges Stockholders to Vote 'for' All Four Co's Director Nominees
Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
Goldman Sachs Maintains Dynavax Technologies(DVAX.US) With Sell Rating, Cuts Target Price to $10
Dynavax, Deep Track Capital Step Up Fight Ahead of June 11 Annual Meeting
Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots.
Express News | Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots
Express News | Deep Track: Dynavax Technologies' Board Rejects Nomination of Four Candidates to Its Board
Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Dynavax Technologies (NASDAQ:DVAX) Pulls Back 6.5% This Week, but Still Delivers Shareholders Strong 31% CAGR Over 5 Years
Are Dynavax Technologies Corporation's (NASDAQ:DVAX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Express News | Reported Earlier, CenterPoint Energy Moves To Reduce Electric Bills By Up To $2 Monthly By 2027
Dynavax Files Preliminary Proxy Statement